The estimated Net Worth of Jack Phillips is at least $925 Mille dollars as of 17 April 2024. Mr Phillips owns over 59,928 units of Accelerate Diagnostics Inc stock worth over $305,343 and over the last 5 years he sold AXDX stock worth over $0. In addition, he makes $619,962 as CEO e Pres & Director at Accelerate Diagnostics Inc.
Mr has made over 26 trades of the Accelerate Diagnostics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 59,928 units of AXDX stock worth $96,484 on 17 April 2024.
The largest trade he's ever made was exercising 350,000 units of Accelerate Diagnostics Inc stock on 8 March 2023 worth over $563,500. On average, Mr trades about 26,589 units every 30 days since 2019. As of 17 April 2024 he still owns at least 189,654 units of Accelerate Diagnostics Inc stock.
You can see the complete history of Mr Phillips stock trades at the bottom of the page.
Jack Phillips is the CEO, Pres & Director at Accelerate Diagnostics Inc.
As the CEO e Pres & Director of Accelerate Diagnostics Inc, the total compensation of Mr Phillips at Accelerate Diagnostics Inc is $619,962. There are 2 executives at Accelerate Diagnostics Inc getting paid more, with John Phillips having the highest compensation of $12,300,900.
Mr Phillips is 55, he's been the CEO e Pres & Director of Accelerate Diagnostics Inc since . There are 9 older and 5 younger executives at Accelerate Diagnostics Inc. The oldest executive at Accelerate Diagnostics Inc is Jack Schuler, 79, who is the Independent Director.
Jack's mailing address filed with the SEC is C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON, AZ, 85714.
Over the last 12 years, insiders at Accelerate Diagnostics Inc have traded over $26,833,308 worth of Accelerate Diagnostics Inc stock and bought 16,366,880 units worth $209,384,489 . The most active insiders traders include Jack W Schuler, Larry N Feinberg e Matthew Strobeck. On average, Accelerate Diagnostics Inc executives and independent directors trade stock every 16 days with the average trade being worth of $132,645. The most recent stock trade was executed by Hany Massarany on 28 June 2024, trading 4,737 units of AXDX stock currently worth $7,627.
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Accelerate Diagnostics Inc executives and other stock owners filed with the SEC include: